Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 329
6
Diseases
14
Unique genes
0.142
Avg. similarity score
Partington syndrome
Most-connected disease (5 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Partington syndrome
X-linked syndromic intellectual disability
Intellectual developmental disorder microcephaly cerebellar
X-linked female restricted facial dysmorphism, short stature, choanal atresia, intellectual disability
X-linked myopathy with excessive autophagy
intellectual disability, X-linked 107
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Partington syndrome | 5 | 5 | 14 |
| X-linked syndromic intellectual disability | 4 | 4 | 8 |
| Intellectual developmental disorder microcephaly cerebellar | 2 | 2 | 1 |
| X-linked female restricted facial dysmorphism, short stature, choanal atresia, intellectual disability | 2 | 2 | 1 |
| X-linked myopathy with excessive autophagy | 2 | 2 | 1 |
| intellectual disability, X-linked 107 | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| CASK | 3 / 6 | Intellectual developmental disorder microcephaly cerebellar, Partington syndrome, X-linked syndromic intellectual disability |
| RPL10 | 3 / 6 | Partington syndrome, X-linked myopathy with excessive autophagy, X-linked syndromic intellectual disability |
| USP9X | 3 / 6 | Partington syndrome, X-linked female restricted facial dysmorphism, short stature, choanal atresia, intellectual disability, X-linked syndromic intellectual disability |
| BRWD3 | 2 / 6 | Partington syndrome, X-linked syndromic intellectual disability |
| DDX3X | 2 / 6 | Partington syndrome, X-linked syndromic intellectual disability |
| LAS1L | 2 / 6 | Partington syndrome, X-linked syndromic intellectual disability |
| NONO | 2 / 6 | Partington syndrome, X-linked syndromic intellectual disability |
| STEEP1 | 2 / 6 | intellectual disability, X-linked 107, Partington syndrome |
| ZC4H2 | 2 / 6 | Partington syndrome, X-linked syndromic intellectual disability |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
None of these pathways reaches significance (all FDR q ≥ 0.05). They’re the best candidates found, but treat them as weak evidence for why this cluster groups together.
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Nef mediated downregulation of MHC class I complex cell surface expression | Reactome | 1 / 10 | 85.8× | 1.16e-2 | 7.50e-2 |
| CD28 dependent Vav1 pathway | Reactome | 1 / 12 | 71.5× | 1.39e-2 | 8.31e-2 |
| Sema3A PAK dependent Axon repulsion | Reactome | 1 / 15 | 57.2× | 1.74e-2 | 9.50e-2 |
| Major pathway of rRNA processing in the nucleolus and cytosol | Reactome | 2 / 184 | 9.3× | 1.88e-2 | 9.94e-2 |
| Ephrin signaling | Reactome | 1 / 19 | 45.2× | 2.19e-2 | 1.08e-1 |
| CD209 (DC-SIGN) signaling | Reactome | 1 / 21 | 40.9× | 2.42e-2 | 1.15e-1 |
| Human immunodeficiency virus 1 infection | KEGG | 2 / 213 | 8.1× | 2.48e-2 | 1.16e-1 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | Reactome | 1 / 22 | 39.0× | 2.54e-2 | 1.17e-1 |
| RHO GTPases activate PAKs | Reactome | 1 / 23 | 37.3× | 2.65e-2 | 1.20e-1 |
| Dopamine Neurotransmitter Release Cycle | Reactome | 1 / 23 | 37.3× | 2.65e-2 | 1.20e-1 |
| VEGFR2 mediated vascular permeability | Reactome | 1 / 29 | 29.6× | 3.33e-2 | 1.37e-1 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | Reactome | 1 / 30 | 28.6× | 3.44e-2 | 1.39e-1 |
| Generation of second messenger molecules | Reactome | 1 / 31 | 27.7× | 3.56e-2 | 1.42e-1 |
| Neurexins and neuroligins | Reactome | 1 / 32 | 26.8× | 3.67e-2 | 1.44e-1 |
| Lysosome Vesicle Biogenesis | Reactome | 1 / 35 | 24.5× | 4.01e-2 | 1.52e-1 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| rhythmic process | GO:0048511 | 3 / 148 | 27.1× | 1.66e-4 | 4.42e-3 ✓ sig. |
| positive regulation of type I interferon production | GO:0032481 | 2 / 54 | 49.4× | 7.29e-4 | 1.23e-2 ✓ sig. |
| regulation of circadian rhythm | GO:0042752 | 2 / 66 | 40.4× | 1.09e-3 | 1.59e-2 ✓ sig. |
| embryonic olfactory bulb interneuron precursor migration | GO:0021831 | 1 / 2 | 667× | 1.50e-3 | 1.91e-2 ✓ sig. |
| negative regulation of cellular response to growth factor stimulus | GO:0090288 | 1 / 2 | 667× | 1.50e-3 | 1.91e-2 ✓ sig. |
| positive regulation of toll-like receptor 8 signaling pathway | GO:0034161 | 1 / 3 | 445× | 2.25e-3 | 2.41e-2 ✓ sig. |
| chromosome segregation | GO:0007059 | 2 / 110 | 24.3× | 2.98e-3 | 2.82e-2 ✓ sig. |
| cerebral cortex tangential migration | GO:0021800 | 1 / 4 | 334× | 2.99e-3 | 2.82e-2 ✓ sig. |
| positive regulation of translation in response to endoplasmic reticulum stress | GO:0036493 | 1 / 4 | 334× | 2.99e-3 | 2.82e-2 ✓ sig. |
| epithelial cell fate commitment | GO:0072148 | 1 / 4 | 334× | 2.99e-3 | 2.82e-2 ✓ sig. |
| regulation of transcription regulatory region DNA binding | GO:2000677 | 1 / 4 | 334× | 2.99e-3 | 2.82e-2 ✓ sig. |
| globus pallidus development | GO:0021759 | 1 / 4 | 334× | 2.99e-3 | 2.82e-2 ✓ sig. |
| cytosolic ribosome assembly | GO:0042256 | 1 / 5 | 267× | 3.74e-3 | 3.18e-2 ✓ sig. |
| lipid digestion | GO:0044241 | 1 / 5 | 267× | 3.74e-3 | 3.18e-2 ✓ sig. |
| noradrenergic neuron development | GO:0003358 | 1 / 5 | 267× | 3.74e-3 | 3.18e-2 ✓ sig. |